CRIP1 Reshapes the Gastric Cancer Microenvironment to Facilitate Development of Lymphatic Metastasis
Advanced Science · 2023-09 · 10 (26)
DOI: 10.1002/advs.202303246 ↗At a glance
Journal article in Advanced Science, published online on 2023-07-06. Written by Zhonghua Wu and 9 co-authors. Institution: Department of Surgical Oncology and General Surgery, The First Hospital of China Medical University, Key Laboratory of Precision Diagnosis and Treatm…. Major MEDLINE topics: Vascular Endothelial Growth Factor C, Stomach Neoplasms. Cited 33 times so far (Crossref); 44 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (original language)
Lymphangiogenesis in tumors provides an auxiliary route for cancer cell invasion to drainage lymph nodes, facilitating the development of lymphatic metastasis (LM). However, the mechanisms governing tumor lymphangiogenesis and lymphatic permeability in gastric cancer (GC) remain largely unknown. Here, the unprecedented role and mechanism of cysteine‐rich intestinal protein‐1 (CRIP1) in mediating the development of GC LM is uncovered. A series of assays are performed to identify downstream targets of CRIP1, and rescue experiments are performed to confirm the effects of this regulatory axis on LM. CRIP1 overexpression facilitates LM in GC by promoting lymphangiogenesis and lymphatic vessel permeability. CRIP1 promotes phosphorylation of cAMP responsive element binding protein 1(CREB1), which then mediates vascular endothelial growth factor C (VEGFC) expression necessary for CRIP1‐induced lymphangiogenesis and transcriptionally promotes C‐C motif chemokine ligand 5 (CCL5) expression. CCL5 recruits macrophages to promote tumor necrosis factor alpha (TNF‐ α ) secretion, eventually enhancing lymphatic permeability. The study highlights CRIP1 regulates the tumor microenvironment to promote lymphangiogenesis and LM in GC. Considering the current limited understanding of LM development in GC, these pathways provide potential targets for future therapeutics.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Surgical Oncology and General Surgery, The First Hospital of China Medical University, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors China Medical University, Ministry of E…
- Institute of Health Sciences, China Medical University, Shenyang, Liaoning, 110122, China.
ORCID profiles: Zhenning Wang
Funding
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Cite
APA
Wu, Z., Qu, B., Yuan, M., Liu, J., Zhou, C., Sun, M., Guo, Z., Zhang, Y., Song, Y., & Wang, Z. (2023). CRIP1 Reshapes the Gastric Cancer Microenvironment to Facilitate Development of Lymphatic Metastasis. Advanced Science, 10(26). https://doi.org/10.1002/advs.202303246
Vancouver
Wu Z, Qu B, Yuan M, Liu J, Zhou C, Sun M, et al. CRIP1 Reshapes the Gastric Cancer Microenvironment to Facilitate Development of Lymphatic Metastasis. Advanced Science. 2023;10(26). doi:10.1002/advs.202303246
BibTeX
@article{Wu2023,
author = {Wu, Zhonghua and Qu, Bicheng and Yuan, Minxian and Liu, Jingjing and Zhou, Cen and Sun, Mingwei and Guo, Zhexu and Zhang, Yaqing and Song, Yongxi and Wang, Zhenning},
title = {CRIP1 Reshapes the Gastric Cancer Microenvironment to Facilitate Development of Lymphatic Metastasis},
journal = {Advanced Science},
year = {2023},
volume = {10},
number = {26},
doi = {10.1002/advs.202303246}
}
EUVIMED